These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7154134)

  • 21. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
    Kuokkanen K
    Curr Med Res Opin; 1976-1977; 4(10):703-5. PubMed ID: 800971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on toxicity of hydrocortisone 17-butyrate 21-propionate -6. Subacute toxicity in dogs by percutaneous administration (author's transl)].
    Tarumoto Y; Sakagawa T; Tsutsui Y; Tokado H; Noda K; Nakane S; Sasajima M; Ohzeki M
    J Toxicol Sci; 1981 Jul; 6 Suppl():121-40. PubMed ID: 7310929
    [No Abstract]   [Full Text] [Related]  

  • 23. [Atrophy of adrenal gland and thymus following cortisol treatment in newborn rats (author's transl)].
    Itoh S; Hirota R
    Nihon Naibunpi Gakkai Zasshi; 1976 Dec; 52(12):1230-42. PubMed ID: 1031675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal rat adrenal growth and steroidogenesis in vitro after maternal dexamethasone treatment.
    Klepac R; Milković K
    Biol Neonate; 1979; 36(3-4):154-9. PubMed ID: 486605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The antiinflammatory effect of budesonide ointment and cream].
    Hiroi J; Fujii T; Satoh S; Yoneda K; Senoh H; Mori J; Kikuchi H
    Nihon Yakurigaku Zasshi; 1985 Sep; 86(3):233-9. PubMed ID: 4085930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of steroid ointments diluted with Compound Zinc Paste B.P.
    Barnes AR; Nash S; Watkiss SB
    J Clin Pharm Ther; 1991 Apr; 16(2):103-9. PubMed ID: 1856247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
    Stein L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two simple methods for the evaluation of topically active anti-inflammatory steroidal ointments.
    Iizuka Y; Endo Y; Misawa Y; Misaka E
    Agents Actions; 1981 May; 11(3):254-9. PubMed ID: 7257953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic toxicity of aclacinomycin A in rats (author's transl)].
    Shirai M; Ohmori K; Hirano S; Iguchi H; Hori S; Sato H
    Jpn J Antibiot; 1980 Mar; 33(3):294-319. PubMed ID: 6931239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Safety evaluation of KW-1062. I. Acute toxicity in mice, rats and dogs, subacute and chronic toxicity in rats (author's transl)].
    Hara T; Koyama K; Miyazaki H; Ohguro Y; Shimizu M
    Jpn J Antibiot; 1977 Jun; 30(6):386-407. PubMed ID: 894836
    [No Abstract]   [Full Text] [Related]  

  • 31. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID.
    WILLIAMS DI; WILKINSON DS; OVERTON J; MILNE JA; MCKENNA WB; LYELL A; CHURCH R
    Lancet; 1964 May; 1(7344):1177-9. PubMed ID: 14132653
    [No Abstract]   [Full Text] [Related]  

  • 32. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
    Satake K; Amano T; Okamoto T
    Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General 4-week toxicity study with EMS in the rat.
    Pfister T; Eichinger-Chapelon A
    Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [PROBLEMS IN THE SIDE-EFFECTS OF ADRENAL CORTEX HORMONE THERAPY OF SKIN DISEASES].
    NOHARA N; TSUKINOKI K; TODA M
    Nisshin Igaku Jpn J Med Prog; 1963 Mar; 50():139-58. PubMed ID: 14058448
    [No Abstract]   [Full Text] [Related]  

  • 36. 28-day oral toxicity study with soft corticosteroid BNP-166 in rats and dogs, followed by a 14-day recovery period.
    Miklós A; Magyar Z; Kiss E; Novák I; Grósz M; Nyitray M; Dereszlay I; Czégeni E; Druga A; Howes J; Bodor N
    Pharmazie; 2002 Feb; 57(2):142-6. PubMed ID: 11878192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks].
    Okazaki S; Nishimura S; Tamura K; Aikawa T; Hatayama K; Tanaka H; Tanaka G
    J Toxicol Sci; 1992 Nov; 17 Suppl 3():91-122. PubMed ID: 1293331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low dose dexamethasone reverses depressive-like parameters and memory impairment in rats submitted to sepsis.
    Cassol OJ; Comim CM; Petronilho F; Constantino LS; Streck EL; Quevedo J; Dal-Pizzol F
    Neurosci Lett; 2010 Apr; 473(2):126-30. PubMed ID: 20184944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of glucocorticoid administration determines severity of lipid metabolism and behavioral effects in rats.
    Wu T; Jiang J; Yang L; Li H; Zhang W; Chen Y; Zhao B; Kong B; Lu P; Zhao Z; Zhu J; Fu Z
    Chronobiol Int; 2017; 34(1):78-92. PubMed ID: 27791398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.